Abstract
Results
In comparison with that in the HC, the percentages of circulating CD14 
Conclusion
Our data suggest that an increase in the frequency of CD14 + CD169 + cells may be associated with the development and progression of CRC and is concomitant rise of both, pro-tumor
Introduction
Colorectal cancer (CRC) is one of the most prevalent malignant tumors with a high mortality.
Its incidence is increasing in many countries and CRC affects > 1.2 million people annually in the world [1] . Previous studies have shown that the development and progression of CRC are associated with local inflammation [2] [3] [4] [5] . Indeed, different types of inflammatory infiltrates, particularly for macrophages, are present in the CRC tissues and the balance of protumor and antitumor inflammatory infiltrates is thought to be critical for the development, progression and invasion of CRC [3] [4] 6] . Hence, illustration of different types of inflammatory infiltrates and their potential functions will be of great significance in understanding the pathogenesis of CRC. Macrophages, as professional antigen-presenting cells (APCs) in the innate immune system, are the most abundant immune cell population in the tumor microenvironment [7, 8] , and play crucial roles in regulating tissue homeostasis and immune status. Macrophages in the gut tissues can be from their self-renewal [9] and can also stem from the migration of monocytes to the intestinal lamina propria, maintaining gut homeostasis [10, 11] . Macrophages can be classically activated into M1 cells that express inducible nitric oxidase (iNOS), IL-12 and high levels of costimulator molecules while resident tissue macrophages and tumor-associated macrophages are likely to express CD163, 206, arginase and IL-10, a M2 phenotype [12] [13] [14] [15] [16] [17] . Furthermore, macrophages, like their parental monocytes, express CD14, a co-receptor of TLR4, which has been commonly used for identifying macrophages and monocytes from intestinal mucosa and peripheral blood [18, 19] . Monocytes and tumor infiltrating macrophages (TIM) also express CD169, sialoadhesin, a cell adhesion molecule [20] and MAC387, a marker for immature macrophages [21] . CD169 + macrophages are important players in the initiation and progression of inflammatory and autoimmune diseases [22] . Furthermore, CD169 + macrophages and monocytes have been thought to dominate pro-inflammation immunity [22] [23] [24] [25] . Previous studies have shown that M2 cells in the tumor environment are associated with the progression and metastasis of cancer [15, [26] [27] . In addition, CD169 + macrophages in regional lymph nodes are associated with a favorable prognosis in CRC patients [28] . However, what type of macrophages in the tumor environment is associated with the progression of CRC remains controversial. It has been confirmed that CD169 + macrophages exit in the colon lamina propria, mainly surrounding the crypts and their development is supported by vitamin A in mice [29] . 
Materials and Methods

Subjects and samples
The written informed consent was obtained from individual participants. The experimental protocol was established, according to the guidelines of the Declaration of Helsinki and was approved by the Human Ethics Committee of Jilin University (Jilin University, Changchun, China). A total of 46 patients with CRC were recruited at the inpatient service of the Department of Colorectal & Anal Surgery, the First Hospital, Jilin University from February 2013 to December 2014. Individual patients were diagnosed by positive fecal occult blood test, histological examination on biopsied tumor tissues obtained during colonoscopy, and a computed tomography (CT) scan. Individual tumor samples were evaluated for their tumor classification, histological grades, and lymph node metastasis status by pathologists in a blinded manner and staged, according to the tumor-node-metastasis (TNM) classification system of International Union against Cancer (Edition 7) [30] . For stratification analysis, patients with stage I/II of CRC were considered at early stage while those with stage III/IV of CRC were considered at advanced stage. Individual patients were excluded if she/he received radiotherapy, chemotherapy, or immunotherapy. In addition, patients were also excluded if she/he had poor physical condition. Another 22 age-and gender-matched healthy subjects and 12 non-tumor subjects were recruited at the Physical Examination Center and another department of the same hospital. All participants had no history of cancer, autoimmune diseases, recent infectious diseases, inflammatory bowel diseases and familial polyposis. Blood samples were obtained from 46 new onset CRC patients, and 22 healthy controls (HC). Surgical colorectal resection tissue samples were obtained from 30 CRC patients and 12 non-tumor controls, who underwent surgical resection of mixed hemorrhoids. Inflammation may be associated with the development of hemorrhoids. However, a previous study has identified that hemorrhoids appears not to be associated with an increased risk for anal cancer [31] and the nature of inflammation between the environments of CRC and hemorrhoids is different. It is reasonable to use these tissues as the non-tumor controls in our study. The demographic and clinical data of individual participants were collected from hospital records and reviewed by experienced surgeons. Their demographic and clinical characteristics are shown in Table 1 .
Isolation of peripheral blood mononuclear cells (PBMCs)
Fasting venous blood samples were collected from individual participants, and one portion of blood was used for preparing peripheral blood mononuclear cells (PBMCs) by density-gradient centrifugation using Ficoll-Paque Plus (GE Healthcare). The remaining blood samples were centrifuged for preparing plasma samples.
Isolation of lamina propria mononuclear cells (LPMCs) and TIMs
The lamina propria mononuclear cells (LPMCs) were isolated from those 12 non-tumor patients and TIMs were isolated from 30 freshly resected surgical tumor specimens, as described previously with minor modification [29, 32] . Briefly, the freshly resected mucosa or CRC tissues were processed within 30 minutes after collection and incubated in calcium and magnesium-free Hanks' balanced salt solution (HBSS, Sigma-Aldrich) containing 2.5% heat-inactivated fetal bovine serum (FBS) and 1 mM dithiothreitol (Sigma-Aldrich) on ice. The tissues were incubated in calcium and magnesium-free HBSS buffer containing 5 mM EDTA, 1 mM dithiothreitol, 2.5% heat-inactivated FBS, 0.1% v/v β-mercaptoethanol (Sigma-Aldrich, St. Louis, USA) at 37°for 25 min under constant stirring to remove mucus and epithelial cells. Subsequently, the remaining segments were cut into small pieces and digested with 250 μg/ml DNAse (Roche) and 125 μg/ml liberaseTM (Roche) in HBSS at 37°for 30 min under constant stirring. After centrifugation, the cells were re-suspended with RPMI-1640 and filtered through a 40 μM cell strainer, followed by loading on the surface of Ficoll-Paque Plus (GE Healthcare). After centrifugation at 800 g for 20 min, the LPMCs and TIMs were recovered from the interface and washed with PBS twice for flow cytometry.
Flow cytometry analysis
To determine the frequency of different subsets of CD14 + cells, PBMCs or LPMCs (10 6 cells/ tube) were stained with Alexa Fluor 647-anti-CD169 (Biolegend), APC-H7-anti-CD14 (BD PharMingen), BV421-anti-CD163 (BD PharMingen) and PerCP-Cy5.5-anti-CD206 (Biolegend) at 4°C for 30 min respectively. Subsequently, the cells were fixed, and permeabilized using the permeabilization solution (BD Biosciences), followed by intracellular staining with FITC-conjugated anti-MAC387 (Abcam). Lipopolysaccharide (LPS) can activate monocytes or macrophages by interacting with TLR4 and CD14 and induce the generation of cytokines such as IL-6, IL-10 and IL-12 [33] [34] . To detect the function, PBMCs or LPMCs (10 6 cells/well) were stimulated in duplicate with 50 ng/ ml of lipopolysaccharide (LPS) and phorbol myristate acetate (PMA) and 1.0 μg/ml of ionomycin (Sigma-Aldrich) in 10% FBS RPMI-1640 medium at 37°C for 2 hours in 5% CO 2 and exposed to Brefeldin A (GolgiPlug; BD Biosciences) for another 4 hours, as described previously in our laboratory (21) . After being washed, were stained with Alexa Fluor 647-anti-CD169, APC-H7-anti-CD14, fixed, and permeabilized using the permeabilization solution, followed by intracellular staining with PE-CF594-anti-IL-10 (JES3-9D7, BD Biosciences) or PE- anti-IL-12 (BD PharMingen). The matched mouse isotype controls of APC-H7-IgG1, FIT-C-IgG1, PE-Ig2a, PerCP-Cy5.5-IgG1, PE-CF594-IgG1 and Alexafluor-IgG1 served as the controls. The mononuclear cells were gated according to cell size and internal structure. To better distinguish positive from negative population, we performed Fluorescence Minus One (FMO), by which, the cells were incubated with all of the fluorochromes except for the one that was being measured (CD14, CD169, CD163). The frequency of different subsets of CD14 + mononuclear cells was determined by flow cytometry analysis on a BD FACSCalibur (Becton Dickinson) and the data were analyzed using FlowJo 7.6.2 software.
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of plasma IL-10 and IL-12p70 in individual participants were determined by ELISA using human IL-10 and IL-12p70 ELISA kits, according to the manufacturers' instruction (R&D Systems). Briefly, human plasma were tested in triplicate and the concentrations of IL-10 and IL-12p70 in individual samples were calculated, according to the standard curves established using recombinant cytokines provided.
Carcinoembryonic antigen (CEA) assay
The concentrations of plasma CEA in individual samples were determined using an ADVIA Centaur XP immunoassay system (Siemens Healthcare Diagnostics, Tarrytown, USA).
Statistical analysis
All data are expressed as individual values, median, and range of each group of subjects. The difference between the groups was analyzed using the Mann-Whitney U test. The difference between the tumor and non-tumor tissues was analyzed using the Wilcoxon signed rank test. The potential correlation between variables was analyzed by the Spearman rank correlation test. All statistical tests were performed using SPSS 19.0. A two-sided P value of <0.05 was considered statistically significant.
Results
Characterization of circulating CD14 + CD169 + monocytes in CRC patients
To determine the potential roles of circulating CD14 + CD169 + monocytes in the development of CRC, a group of CRC patients and age and gender-matched HC were recruited. As shown in Table 1 , there was no significant difference in the distribution of age and gender, the numbers of WBC and monocytes between the patients and HC. Furthermore, there was no significant difference in the tumor location and their differential grades between patients with early and advanced CRC. As expected, the patients displayed significantly higher levels of plasma CEA than the HC (P<0.05 non-tumor patients and in TIMs from 30 CRC patients were analyzed by flow cytometry (Fig 2A) . Although previous studies have shown that macrophages in the gut lamina propria can express different levels of CD14 [18, 36] , a fraction of CD14 + macrophages were presented in the lamina propria (S1 Fig A) + circulating monocytes and TIMs were determined by flow cytometry (Fig 3A) . The percentages of IL-10 + CD14 + CD169 + circulating monocytes and TIMs in total CD14 + CD169 + cells from CRC patients were significantly higher than that from the non-tumor subjects (3.79% vs. 0.76%, P<0.0001 for circulating monocytes; 7.12% vs. 1.23%, P<0.0001 for TIMs. Fig 3B) . In contrast, there was no significant difference in the frequency of IL-12 + CD14 + CD169 + circulating monocytes and TIMs between the CRC patients and non-tumor subjects (0.24% vs. 0.22%, P = 0.2854 for circulating monocytes; 0.37% vs. 0.36%, P = 0.4729 for TIMs. Fig 3C) . for circulating monocytes; R = 0.5637, P = 0.0009 for TIMs, Fig 3D and 3E) . Hence, CRC patients displayed a higher frequency of IL-10 + CD14 + CD169 + macrophages.
We measured the concentrations of plasma IL-10 and IL-12 in individual subjects by ELISA. As shown in Fig 3F and 3G , the concentrations of plasma IL-10, but not IL-12, in the CRC patients were significantly higher than that in the HC (P<0.0001). The concentrations of plasma IL-10 were correlated positively with the percentages of circulating IL-10 + CD14
+-CD169 + monocytes (R = 0.6018, P<0.0001; Fig 3H) and the levels of plasma CEA in the CRC patients (R = 0.413, P = 0.0043; Fig 3I) .
Stratification analyses of the frequency of CD14 + CD169 + monocytes and macrophages in CRC patients Next, we stratified the patients, according to their tumor pathological TNM stages and we found that the percentages of CD14 + CD169 + circulating monocytes were significantly lower in the patients with early stage of CRC than those with advanced stage of CRC (11.81% vs. 15.91%, P = 00003, Fig 4A) . Similarly, the percentages of CD14 + CD169 + macrophages in TIMs from the patients with early stage of CRC were significantly lower than that in those with advanced stage of CRC (22.45% vs. 26.93%, P<0.0001, Fig 4A) . In addition, the percentages of CD14 + CD169 + circulating monocytes from patients with either early stage or advanced stage of CRC were significantly lower than that in TIMs from the same group of patients (P<0.00001, P<0.0001, respectively; Fig 4A) . The percentages of CD14 + CD169 + circulating monocytes were positively correlated with the percentages of CD14 + CD169 + macrophages in
TIMs from the patients with early (R = 0.4361, P = 0.0073. Fig 4B) or advanced stage (R = 0.8191, P = 0.0001. Fig 4C) of CRC. The levels of plasma CEA remain a valuable biomarker for evaluating the CRC progression [39] . Thus, we examined the potential association among the percentages of circulating monocytes and TIMs with the levels of plasma CEA in the CRC patients. We found that the levels of plasma CEA were correlated positively with the percentages of CD14 + CD169 + circulating monocytes (R = 0.7655, P < 0.0001; Fig 4D) and CD14 + CD169 + macrophages in TIMs (R = 0.5768, P = 0.0009; Fig 4E) TIMs were associated with the pathogenic stages of CRC. To the best of our knowledge, this was the first report that significantly higher percentages of circulating CD14 + CD169 + M2-like monocytes or TIMs were associated with pathogenic progression of CRC in humans. Inflammatory infiltrates in the tumor microenvironment are crucial for the progression and metastasis of tumors [7, 8] . Previous studies have shown that alternatively activated M2 macrophages can participate in the pathogenic process of different types of solid tumors by promoting angiogenesis and metastasis and inhibiting antitumor activity [16, [40] [41] . In this study, we detected a significantly higher frequency of circulating and tumor infiltrating CD14 + CD169 TIMs were associated with the pathogenic degrees of CRC. Our data extended previous observations on inflammatory disease and suggest that CD169 + can be expressed by macrophages in tumor tissues [23] [24] [25] 42] . Indeed, CD169 + macrophages have been detected in normal colon lamina propria [29] . Given that CD169 is an adhesion molecule it is possible that CD14 +-CD169 + circulating monocytes may migrate and be activated in the tumor environment to regulate the progression and metastasis of CRC. Our results were different from a previous observation that CD169 + macrophages in regional lymph nodes were associated with a favorable prognosis in CRC patients [28] . On the one hand, the difference may stem from different groups of patients with different genetic backgrounds between our study and those of others. On the other hand, CD169 is expressed not only on CD163 + or CD206 + M2-like macrophages, but also on other subtypes of macrophages. Moreover, tumor-microenvironment consists of many components, which can educate CD169 + macrophages to support tumorigenesis. However, further studies are needed to clarify the function of tumor infiltrating CD169 + macrophages in the development and progression of CRC. The levels of plasma CEA have been considered as a biomarker for evaluating the development, progression and recurrence of CRC in the clinic. Previous studies have shown that the frequency of CD169 + monocytes is associated with the disease activity in autoimmune diseases, such as systemic sclerosis [23] , systemic lupus erythematosus [24] and rheumatoid arthritis [25] . In this study, we detected abnormally higher levels of plasma CEA in CRC patients, particularly in those with advanced stage of CRC. More importantly, the levels of plasma CEA were correlated positively with the percentages of CD14 + CD169 + circulating monocytes and TIMs were significantly higher in CRC patients than in the HC or the non-tumor patients following in vitro activation. However, the percentages of CD14 + CD169 + cells that responded to in vitro stimulation were low although they were similar to 6.3% CD14 + monocytes in a previous study [34] . The lower frequency of CD14 + CD169 + cells responding to stimulation may stem from a non-optimal condition for stimulation or low sensitivity to detect cytoplasmic cytokines. In addition, we detected a higher levels of plasma IL-10, but not IL-12 in CRC patients. Previous studies have shown that tumor associated macrophages express a wide range of molecules, such as TGF-β, arginase-1, EGF, VEGF and IL-10 [27, [43] [44] . Furthermore, another study has indicated that IL-10 + tumor associated macrophages promote the growth of tumors in an IL-10 dependent manner [17] . Indeed, IL-10 secreted by M2-like macrophages induces B2H1 over-expression to inhibit T cells activation and antitumor immunity [45] . The increased frequency of CD14 + CD169 + IL-10 + macrophages in tumor tissues may create a protumor immunosuppressive microenvironment to promote the progression of CRC. Thus, we are interested in further investigating how the CD14 + CD169 + macrophages in the tumor microenvironment regulate the progression and metastasis of CRC. We recognized that our study had limitations, including a small sample size and the lack of functional studies of CD14 
